Avadel Pharmaceuticals PLC (NASDAQ:AVDL)
| 5.68 Delayed Data As of Jan 26 |  -0.07 / -1.22%Today’s Change | 4.93 Today|||52-Week Range 11.59 | -29.70% Year-to-Date |
Latest AVDL News | Press Releases
No recent news for Avadel Pharmaceuticals PLC.
Today’s Trading
| Previous close | 5.75 |
| Today’s open | 5.90 |
| Day’s range | 5.62 - 6.15 |
| Volume | 21,811 |
| Average volume (3 months) | 666,125 |
| Market cap | $324.2M |
Data as of 4:00pm ET, 01/26/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -1,144.62% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -62.28% |
| P/E ratio | NM |
| Price/Sales | 16.43 |
| Price/Book | 2.01 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OMEROmeros Corp | -0.07 | -1.30% |
| AERIAerie Pharmaceutical... | -0.11 | -1.54% |
| ORMPOramed Pharmaceutica... | -0.08 | -0.92% |
| GRTSGritstone bio Inc | -0.11 | -2.13% |
Data as of 4:00pm ET, 01/26/2022
Financials
| Next reporting date | March 8, 2022 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $22.3M |
| Annual profit (last year) | $7.0M |
| Net profit margin | 31.47% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
